Post job

X4 Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Paula Ragan is the X4 Pharmaceuticals's CEO. X4 Pharmaceuticals has 50 employees, of which 15 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The X4 Pharmaceuticals executive team is 20% female and 80% male.
  • 63% of the management team is White.
  • 9% of X4 Pharmaceuticals management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at X4 Pharmaceuticals?
Share your experience

Rate X4 Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Paula Ragan

CEO / President

Art Taveras Ph.D.

Chief Scientific Officer

Art Taveras Ph.D.'s LinkedIn

R&D leader with extensive hands-on experience in efficiently discovering and developing small molecule drugs for the treatment of Neurodegeneration, Cancer, Dysregulated Immune Disorders and Metabolic Diseases. Led and/or contributed to 48 Discovery programs, 15 Pre-Clinical Development candidates, 6 Clinical candidates, 2 FDA approved drugs which have advanced in |55 human clinical trials. |130 Issued patents and patent applications; |90 publications.

Renato Skerlj

Founder

Richard Peters

Founder

Henri Termeer

Founder

Keith Flaherty

Founder

Gary J. Bridger

Board Member

Michael S. Wyzga

Board Member

William Aliski

Board Member

Murray W. Stewart

MD

Do you work at X4 Pharmaceuticals?

Does the leadership team provide a clear direction for X4 Pharmaceuticals?

X4 Pharmaceuticals jobs

X4 Pharmaceuticals founders

Name & TitleBio
Art Taveras Ph.D.

Chief Scientific Officer

Art Taveras Ph.D.'s LinkedIn

R&D leader with extensive hands-on experience in efficiently discovering and developing small molecule drugs for the treatment of Neurodegeneration, Cancer, Dysregulated Immune Disorders and Metabolic Diseases. Led and/or contributed to 48 Discovery programs, 15 Pre-Clinical Development candidates, 6 Clinical candidates, 2 FDA approved drugs which have advanced in |55 human clinical trials. |130 Issued patents and patent applications; |90 publications.

Renato Skerlj

Founder

Richard Peters

Founder

Henri Termeer

Founder

Keith Flaherty

Founder

X4 Pharmaceuticals board members

Name & TitleBio
Paula Ragan

CEO / President

Gary J. Bridger

Board Member

Michael S. Wyzga

Board Member

William Aliski

Board Member

Mary Dibiase

VP Technical Operations and Quality

X4 Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of X4 Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about X4 Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at X4 Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by X4 Pharmaceuticals. The data presented on this page does not represent the view of X4 Pharmaceuticals and its employees or that of Zippia.

X4 Pharmaceuticals may also be known as or be related to X4 PHARMACEUTICALS, INC, X4 Pharmaceuticals and X4 Pharmaceuticals, Inc.